|
AnsporDrug - Anspor The trade name of the product as shown on the labeling.
Dosage -
FOR SUSPENSION; ORAL
Active Ingredient(s) -
Cephradine
Strength -
125MG/5ML
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
061866
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Glaxosmithkline
Anspor
Cephradine 500mg Capsule; Oral
Velosef 250mg Capsule; Oral Velosef 500mg Capsule; Oral Velosef '250' 250mg Capsule; Oral Velosef '500' 500mg Capsule; Oral Anspor 125mg/5ml For Suspension; Oral Cephradine 500mg Capsule; Oral Cephradine 250mg Capsule; Oral Cephradine 500mg Capsule; Oral Cephradine 250mg Capsule; Oral NewDrugInformation |